Raymond James downgrades Ameris Bancorp stock rating on valuation

Raymond James downgraded Ameris Bancorp (ABCB) to Market Perform from Outperform, citing limited upside for valuation expansion as the stock is near its $52-week high (trading at $90.26 vs. $91.41) and already commands a premium multiple. The call is tempered by stronger-than-expected Q1 2026 results (EPS $1.63 vs. $1.55; revenue $314.36M vs. $309.32M) and a new $0.20 quarterly dividend, but competitive pressure is weighing on net interest margin per management guidance. Net impact is likely to be mostly stock-specific as the risk-reward is framed as balanced rather than bullish.

Analysis

This is less about a broken franchise and more about the market running out of ways to pay up for it. In regional banks, once a name is priced as a quality compounder, the next leg depends on either faster spread expansion or a cleaner funding advantage; if deposit competition stays tight, earnings can still rise while the multiple quietly compresses. That favors relative shorts in premium-valued lenders and leaves the broader regional basket less exposed than the single-name story.

Near term, the stock can keep drifting sideways because buyback/dividend support and decent execution make it hard to press a bearish outright view. The better 1-3 month catalyst is not a macro surprise but the next guidance reset: if management has to keep acknowledging margin pressure, the market can shave 1-2 turns off valuation even without a fundamental miss. Over 6-18 months, the Southeast growth narrative becomes less differentiated if rivals keep chasing the same loan growth with similar funding costs.

Contrarian take: the consensus may be over-optimizing the importance of multiple expansion and underestimating total return from steady compounding. That argues for a hold-to-light-underweight, not an aggressive short, unless deposit betas or net interest margin trends worsen on the next print. The thesis fails if the next earnings cycle shows stable NIM plus re-accelerating loan growth, which would reopen the rerating case.

Key Decisions for Investors

• Trim/add no new capital to ABCB on strength near highs; if already long, monetize via 1-2 month covered calls around 5-8% OTM to capture premium while upside is capped.
• Relative-value trade: short ABCB vs. long KRE for 1-3 months as a hedge against regional-banking beta while isolating valuation compression in the premium name; cover if ABCB’s next guide shows NIM stabilization.
• Set an earnings alert on ABCB’s next print: if NIM guidance is revised lower again or deposit costs continue rising faster than loan yields, use that as the trigger to add to a tactical short.
• If seeking long bank exposure, prefer lower-multiple regionals over ABCB until the market proves funding pressure is easing; avoid paying up for growth that is already priced.